Literature DB >> 18584565

Therapy for acute retinal necrosis.

Tatsushi Kawaguchi1, Doran B Spencer, Manabu Mochizuki.   

Abstract

Acute retinal necrosis is a progressive necrotizing retinopathy caused by herpes simplex virus (HSV) or varicella zoster virus (VZV). The mainstay of its treatment is antiviral therapy against these pathogenic organisms, such as intravenous acyclovir or oral valacyclovir. Systemic and topical corticosteroids together with antiviral therapy are used as an anti-inflammatory treatment to minimize damages to the optic nerve and retinal blood vessels. Because the majority of severe cases of the disease show occlusive retinal vasculitis, a low dosage of aspirin is used as anti-thrombotic treatment. Vitreo-retinal surgery is useful to repair rhegmatogenous retinal detachment, one of the main late-stage complications. Moreover, recent articles have reported some encouraging results of prophylactic vitrectomy before rhegmatogenous retinal detachment occurs. The efficacy of laser photocoagulation to prevent the development or extension of rhegmatogenous retinal detachment is controversial. Despite these treatments, the visual prognosis of acute retinal necrosis is still poor, in particular VZV-induced acute retinal necrosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18584565     DOI: 10.1080/08820530802111192

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  16 in total

Review 1.  Advances in the management of acute retinal necrosis.

Authors:  Jessica G Shantha; Heather M Weissman; Matthew R Debiec; Thomas A Albini; Steven Yeh
Journal:  Int Ophthalmol Clin       Date:  2015

2.  Bilateral acute retinal necrosis after bilateral cataract surgery in an immunocompromised patient: a case report.

Authors:  Chun Yue Mak; Helena Pui-Yee Sin; Mary Ho; Vesta Cheuk-Ki Chan; Alvin Lerrmann Young; Marten Erik Brelen
Journal:  Int Ophthalmol       Date:  2017-05-23       Impact factor: 2.031

3.  Combination systemic and intravitreal antiviral therapy in the management of acute retinal necrosis syndrome (an American Ophthalmological Society thesis).

Authors:  Christina J Flaxel; Steven Yeh; Andreas K Lauer
Journal:  Trans Am Ophthalmol Soc       Date:  2013-09

4.  Efficacy and necessity of prophylactic vitrectomy for acute retinal necrosis syndrome.

Authors:  Yong-Heng Luo; Xuan-Chu Duan; Bai-Hua Chen; Luo-Sheng Tang; Xiao-Jian Guo
Journal:  Int J Ophthalmol       Date:  2012-08-18       Impact factor: 1.779

5.  Valacyclovir as Initial Treatment for Acute Retinal Necrosis: A Pharmacokinetic Modeling and Simulation Study.

Authors:  Tao Liu; Aabha Jain; Michael Fung; Christopher Vinnard; Vijay Ivaturi
Journal:  Curr Eye Res       Date:  2017-03-30       Impact factor: 2.424

6.  Antiviral selection in the management of acute retinal necrosis.

Authors:  Patrick M K Tam; Claire Y Hooper; Susan Lightman
Journal:  Clin Ophthalmol       Date:  2010-02-02

Review 7.  [Acute retinal necrosis].

Authors:  A Gandorfer; S Thurau
Journal:  Ophthalmologe       Date:  2009-08       Impact factor: 1.059

8.  Time profile of viral DNA in aqueous humor samples of patients treated for varicella-zoster virus acute retinal necrosis by use of quantitative real-time PCR.

Authors:  D Bernheim; R Germi; M Labetoulle; J P Romanet; P Morand; C Chiquet
Journal:  J Clin Microbiol       Date:  2013-05-01       Impact factor: 5.948

9.  Acute retinal necrosis after Boston type I keratoprosthesis.

Authors:  Abdullah M Al-Amri; Saba Al-Rashaed; Sulaiman Al-Kharashi
Journal:  Middle East Afr J Ophthalmol       Date:  2012 Apr-Jun

10.  Valacyclovir in the treatment of acute retinal necrosis.

Authors:  Simon Rj Taylor; Robin Hamilton; Claire Y Hooper; Lavnish Joshi; Jiten Morarji; Nitin Gupta; Sue L Lightman
Journal:  BMC Ophthalmol       Date:  2012-09-05       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.